Bangalore Pharma Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.33 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -8.24%
- Profit Growth -54.59%
- Ebitda 17.37%
- Net Worth 2.62%
- Total Assets -1.42%
About Bangalore Pharma Formulations
Bangalore Pharma Formulations Private Limited (BPFPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2006 and has a history of 18 years and 11 months. Its registered office is in Kannur, Kerala, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.33 M, as per Ministry of Corporate Affairs (MCA) records.
Cyriac Kappen, Sudhakar Viswanathan, Shajan Mekkattuparambil, and One other member serve as directors at the Company.
Company Details
-
Location
Kannur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232KL2006PTC019217
-
Company No.
019217
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Bangalore Pharma Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameshkumar Kizahaparambil
|
Managing Director | 21-Mar-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Cyriac Kappen
|
Director | 31-Dec-2018 | Current |
|
Sudhakar Viswanathan
|
Director | 31-Dec-2018 | Current |
|
Shajan Mekkattuparambil
|
Director | 31-Dec-2018 | Current |
Financial Performance of Bangalore Pharma Formulations.
Bangalore Pharma Formulations Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 8.24% decrease. The company also saw a substantial fall in profitability, with a 54.59% decrease in profit. The company's net worth moved up by a moderate rise of 2.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bangalore Pharma Formulations?
In 2017, Bangalore Pharma Formulations had a promoter holding of 67.96% and a public holding of 32.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
North Malabar Chamber Of CommerceRameshkumar Kizahaparambil is a mutual person
-
Qmar Lifesciences LlpRameshkumar Kizahaparambil is a mutual person
-
Pharmia Bio Genesis Private Limited
Rameshkumar Kizahaparambil is a mutual person
-
Kanhangad Links Private Limited
Rameshkumar Kizahaparambil is a mutual person
-
Emmar Drug Links Private Limited
Rameshkumar Kizahaparambil is a mutual person
-
Newniz Developers Private Limited
Rameshkumar Kizahaparambil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bangalore Pharma Formulations?
Unlock and access historical data on people associated with Bangalore Pharma Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bangalore Pharma Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bangalore Pharma Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
